Natures Sunshine Products Inc
NASDAQ:NATR
Natures Sunshine Products Inc
Natures Sunshine Products, Inc. engages in the manufacturing and direct selling of nutritional and personal care products. The company is headquartered in Lehi, Utah and currently employs 850 full-time employees. The company went IPO on 2009-06-25. The firm has four segments: Asia, Europe, North America, and Latin America and Other. Its segments operate under the Nature's Sunshine Products and Synergy WorldWide brands. Its products are grouped into six principal categories, such as general health, immune, cardiovascular, digestive, personal care and weight management. Its general health category is a combination of assorted health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. Its immune category offers products that support and strengthen the human immune system. Its cardiovascular category is designed to offer products that combine a variety of superior heart health ingredients to give the cardiovascular system optimum support.
Natures Sunshine Products, Inc. engages in the manufacturing and direct selling of nutritional and personal care products. The company is headquartered in Lehi, Utah and currently employs 850 full-time employees. The company went IPO on 2009-06-25. The firm has four segments: Asia, Europe, North America, and Latin America and Other. Its segments operate under the Nature's Sunshine Products and Synergy WorldWide brands. Its products are grouped into six principal categories, such as general health, immune, cardiovascular, digestive, personal care and weight management. Its general health category is a combination of assorted health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. Its immune category offers products that support and strengthen the human immune system. Its cardiovascular category is designed to offer products that combine a variety of superior heart health ingredients to give the cardiovascular system optimum support.
Record Quarter: Nature's Sunshine delivered its best quarter ever, with net sales hitting a record $128.3 million, up 12% year-over-year.
Margin Expansion: Gross margin rose 200 basis points to 73.3%, the highest in 15 quarters, due to cost initiatives and favorable product mix.
Digital Acceleration: North America's digital sales grew 52% and digital investment is driving both new customer acquisition and higher retention, especially with autoship subscriptions.
Asia Pacific & China Upside: APAC sales climbed 17%, with China rebounding thanks to a new autoship program now representing 12% of sales.
Raised Guidance: Full-year 2025 sales guidance was increased to $476–480 million (from $460–475 million) and EBITDA guidance to $47–49 million (from $41–45 million).
Share Buybacks: The company repurchased 1.1 million shares for $14.4 million so far in 2025, with $19.3 million remaining on the program.
Zero Debt, Strong Cash: Nature's Sunshine ended Q3 with $95.6 million in cash and no debt.
